Home > News > S.A. firm licenses stent technology
December 15th, 2005
S.A. firm licenses stent technology
Abstract:
Advanced Bio Prosthetic Surfaces confirmed that it has licensed its stent-making technology for $10 million to Cordis Corp., a Johnson & Johnson company. Using a process known as nanosynthesis, Advanced Bio's researchers have improved the material used to make the stent, which leads to fewer impurities.
Source:
mysanantonio.com
Bookmark:
Nanomedicine
Nanoparticle Harnesses Powerful Radiation Therapy for Cancer May 20th, 2013
Microneedle-Delivered Nanoparticles Boost Antitumor Vaccines May 20th, 2013
New Nanopore Sensor Simplifies Analysis of Methylated DNA May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Announcements
International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013
Iran to Hold 1st Conference on Applications of Nanotechnology in Energy Industry May 21st, 2013
Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013